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Abstract
Background: Facial emotion perception is a major social skill, but its molecular signal pathway remains unclear. The MET/
AKT cascade affects neurodevelopment in general populations and face recognition in patients with autism. This study
explores the possible role of MET/AKT cascade in facial emotion perception.
Methods: One hundred and eighty two unrelated healthy volunteers (82 men and 100 women) were recruited. Four single
nucleotide polymorphisms (SNP) of MET (rs2237717, rs41735, rs42336, and rs1858830) and AKT rs1130233 were genotyped
and tested for their effects on facial emotion perception. Facial emotion perception was assessed by the face task of Mayer-
Salovey-Caruso Emotional Intelligence Test (MSCEIT). Thorough neurocognitive functions were also assessed.
Results: Regarding MET rs2237717, individuals with the CT genotype performed better in facial emotion perception than
those with TT (p=0.016 by ANOVA, 0.018 by general linear regression model [GLM] to control for age, gender, and
education duration), and showed no difference with those with CC. Carriers with the most common MET CGA haplotype
(frequency=50.5%) performed better than non-carriers of CGA in facial emotion perception (p=0.018, df=1, F=5.69,
p=0.009 by GLM). In MET rs2237717/AKT rs1130233 interaction, the C carrier/G carrier group showed better facial emotion
perception than those with the TT/AA genotype (p=0.035 by ANOVA, 0.015 by GLM), even when neurocognitive functions
were controlled (p=0.046 by GLM).
Conclusions: To our knowledge, this is the first study to suggest that genetic factors can affect performance of facial
emotion perception. The findings indicate that MET variances and MET/AKT interaction may affect facial emotion perception,
implicating that the MET/AKT cascade plays a significant role in facial emotion perception. Further replication studies are
needed.
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Introduction
Facial emotion perception is a key element of social function
[1,2,3]. Patients with schizophrenia have deficits in not only facial
emotion expression [4,5] but also facial emotion perception [6].
Better facial emotion perception is related to better work
functioning and independent living in patients with schizophrenia
[7]. Unaffected siblings of schizophrenia patients are also impaired
in emotion perception [8,9,10], implying that deficits in facial
emotion perception may transmit in families and serve as a
heritable endophenotype of schizophrenia. Facial emotion pro-
cessing is mainly executed in amygdala, right fusiform gyri, and
hippocampus in both schizophrenia patients and healthy individ-
uals [11,12]. Compared to healthy controls, schizophrenic patients
have a hypoactivation of amygdala and hippocampus when
processing facial emotions [11,12]. Relative to healthy subjects
without family history of psychosis, healthy offspring of schizo-
phrenia patients also have reduced amygdala activity in response
to positive emotional faces [13].
Several studies, focusing on monoamine pathways, suggest that
genetic variances can determine activities of relevant brain regions
when people perceive facial emotion. Non-depressed adults with
short allele of deletion polymorphism in the serotonin transporter-
linked polymorphic region (5-HTTLPR) have impaired emotion
processing and difficulty disengaging attention from facial stimuli
[14]. Healthy subjects carrying G allele of serotonin 1A (5HT1A)
C(-1019)G polymorphism have decreased amygdala activity when
perceiving fear face [15]. Normal individuals with C/C genotype
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amygdala activity than C/T heterozygotes when performing facial
recognition tasks [16]. Bipolar patients’ family members who have
Val158 allele of catechol-O-methyltransferase (COMT) valine-to-
methionine (Val158Met) polymorphism have greater amygdala
activity upon receiving sad facial stimuli [17]. COMT Val158Met
polymorphism also affects early phase of facial stimuli processing
in children [18].
However, whether genetic factors can affect performance of
facial emotion perception remains uncertain. In addition, the
signal cascades of facial emotion perception deserve further studies
because accumulating evidence suggests that regardless of the
underlying genetic complexity, the pathophysiology and endophe-
notypes of schizophrenia may be determined by a small number of
common signaling pathways [19,20].
MET, located at chromosome 7q31, is expressed in amygdala,
hippocampus, and cerebral cortex [21,22,23]. With 21 exons,
MET is vital for cerebral and cerebellar development
[24,25,26,27] and interneuron migration, which is implicated in
pathophysiology of neurodevelopment disorders such as autism
and schizophrenia [27,28,29]. MET is associated with autism
[29,30,31,32] and face recognition in autistic patients [33,34,35].
Schizophrenia shares common genetic factors and clinical features
with autism [36,37]. Furthermore, Burdick et al found that most
common GCAATACA haplotype (47%) from rs38857-
rs10215153- rs2237717 - rs2283053- rs41735 - rs41741- rs42336
- rs41750 is less-represented in schizophrenia patients and related
with better cognitive performances in the healthy group [37].
Among the 8 SNPs, rs2237717, rs41735, and rs42336 were
significantly associated with schizophrenia in two independent
case-control comparisons [37]. Moreover, MET promoter SNP
rs1858830 has been shown to alter gene transcription [29] and be
correlated with levels of MET protein [38]. In the current study,
we focused on these 4 SNPs.
MET activates phosphorylation of AKT, and this cascade is
essential for anti-apoptotic signaling [39] and neuroprotection [40].
The AKT gene is also associated with schizophrenia [41,42,43].
Haloperidol, a dopamine receptor antagonist, can increase
phosphorylation of AKT proteins in brains of mice, implying that
AKT may be involved in the dopamine neurotransmission pathway
[41]. One SNP (rs1130233) of AKT can affect amount of AKT
protein in lymphocytes and postmortem frontal cortex and
hippocampus regions [41]. Subjects with the A allele of AKT
rs1130233 have impaired executive function, processing speed, trail
making, verbal and category fluency and prefrontal cortical
structure [44]. AKT is also involved in fear memory learning via
the amygdala, a crucial area for emotion perception [45]. However,
the role of AKT in emotion perception requires elucidation.
This study aimed to testify the genetic effects of the MET and
AKT cascade on facial emotion perception in healthy individuals.
Methods
This study was approved by the Institutional Review Board of
China Medical University Hospital (CMUH), the authors’
institutional review board, and performed in accordance with
the Declaration of Helsinki. After complete description, all subjects
gave written informed consent.
Subjects
The participants were 182 unrelated Han Chinese healthy
individuals (82 men and 100 women) with a mean age of 31.52
(SD=9.58, range 20–65) years and a mean education level of
14.91 (SD=2.21, range 6–23 years). All were Han Chinese living
in Taiwan. They were free of any axis I or II psychiatric disorders,
as determined by a research psychiatrist using the Structured
Clinical Interview for DSM-IV [46]. They were also in good
physical health, as determined by physical examination, electro-
cardiogram and laboratory tests including liver, renal and thyroid
function tests and urinalysis. After complete description, all
subjects gave written informed consent.
Measurement of facial emotion perception
This study utilized the face task of the emotion perception
branch of Mayer-Salovey-Caruso Emotional Intelligence Test
(MSCEIT) [47]. MSCEIT is divided into four branches:
perceiving emotion (consisting of two tasks: face and picture
tasks), facilitating emotion, understanding emotion, and managing
emotion [48]. The face task of emotion perception could reflect
the ability of being aware of emotional cues before identifying
what they mean accurately. In the face task (with four item parcels,
each with five responses), participants viewed a series of faces and
responded to each one on a five-point scale, indicating the degree
to which a specific emotion was present in a face. Patients rated all
of the five emotions (happiness, sadness, fear, surprise, and
excitement) sequentially [47]. The results were scaled to a
standard score based on the weight from the representative adult
population (regarding age, gender, and ethnicity) in an extremely
large sample of people (5,000) [47]. The reliability and validity of
MSCEIT V2.0 have been demonstrated to be favorable in various
races [47,49] including Han-Chinese [50].
Measurement of cognitive functions
An experienced research psychologist comprehensively assessed
cognitive functions to control for their possible effects when we
explored genetic effects on facial emotion perception. Among all
182 subjects, 149 also received thorough cognition assessments
with a battery of tests, which were the same as or the analogues of
tests from Measurement and Treatment Research to Improve
Cognition in Schizophrenia (MATRICS) [51,52]. This battery
included 7 domains: (1) speed of processing, consisting of 3 tests:
Category Fluency, Trail Marking A, and WAIS-III Digit Symbol-
Coding [53,54]; (2) sustained attention by Continuous Perfor-
mance Test [55]; (3) working memory, verbal (backward digit
span) and nonverbal (WMS-III, Spatial Span) [56]; (4) verbal
learning and memory (WMS-III, word listing) [56]; (5) visual
learning and memory (WMS-III, visual reproduction) [56]; (6)
reasoning and problem solving (WISC-III, Maze) [57], and (7)
social cognition, measured by the managing emotions branch of
MSCEIT [47]. Mean score of each domain was standardized to a
T score with a mean of 50 and a standard deviation of 10. For the
domain with more than one test, an overall composite score was
calculated by standardizing the sum of T scores [58].
DNA extraction
Peripheral bloods from schizophrenia subjects were collected in
EDTA-tubes. The DNA was isolated by employing the salting-out
method [59], and stored in a TE-buffer at 2–8uC. The sample
concentrations were measured with a UV/Vis spectrophotometer
(Nanodrop ND-1000, Thermo Scientific).
Genotyping
Four SNPs (rs2237717, rs41735, rs42336, and rs1858830) of the
MET gene and rs1130233 of the AKT gene were selected due to
associations with schizophrenia [37,41,44] and with performances
of neurocognition tests in previous studies [37,44]. To determine
genotyping from venous blood samples, the 5 SNPs expect
MET/AKT Gene on Facial Emotion Perception
PLoS ONE | www.plosone.org 2 April 2012 | Volume 7 | Issue 4 | e36143rs1858830 were amplified via PCR amplification before being
subjected to analysis by high resolution melting method (HRM) in
ABI 7500 Fast Real-time PCR system (Life technologies).
The sequences of the primers for the MET gene were: for
rs2237717, sense primer 59- CCA CGT ACT TCA TCA ATG -39
and antisense primer 59- CTT CCT GGC AAT AAA GAG -39;
for rs41735, sense primer 59- GCT ATT GGA AAA GAA AAG
GAT AGA AAC -39 and antisense primer 59- CCA TCT GTA
GTT GGT AGA ATA TCT CT -39; for rs42336, sense primer 59-
AGA GAA CTA GAT TAC GTC AGC CAA AGA -39 and
antisense primer 59- TCT GCC CTG GGG TCA CAT -39. For
rs1130233 of AKT, sense primer 59-GCT GTT CTT CCA CCT
GTC -39 and antisense primer 59-AGG GCT GAC ACA ATC
TCA -39. Neither a TaqMan Assay-by-Design nor a high
resolution melting method (HRM) in ABI 7500 Fast Real-time
PCR system (Life technologies) was able to reliably provide
rs1858830 genotype from genomic DNA, probably because of
<85% GC in the region. Therefore the genotype at rs1858830
was determined by direct resequencing.
PCR was performed in a 20-ml volume containing the following:
16 PCR reaction buffer, 1 U FastStart Taq DNA Polymerase
(Roche), 0.3 mM of each primer, 1.5 mM SYTOH 9 green
fluorescent nucleic acid stain (Life technologies), and 20 ng
DNA template, with a 2 mM final MgCl2 concentration. The
cycling conditions were as follows: denaturation at 95uC for 4 min,
followed by 35 cycles of 95uC for 30 s, 58–64uC for 30 s (for MET
gene: rs2237717 and rs41735 at 58uC; rs42336 at 64uC, and for
AKT gene: rs1130233 at 63uC), and 72uC for 45 s, followed by one
HRM cycle of 95uC for 10 s, 60uC for 1 min, and continuous
acquisition to 95uC for 15 s (ramp rate 1%), and subsequently
down to 60uC for 15 s. The HRM data were analyzed using the
high resolution melting (HRM) software, version 2.0.1. All melting
curves deviating from the wild-type curve and appearing as a
different color in discrete plots contain a variant potentially. In
addition, 24 randomly selected samples including three genotypes
of one SNP which identified by HRM were sent to direct
sequencing by Mission Biotech CO., LTD, Taiwan.
Data analysis
All the statistical analyses were performed with the Statistical
Package for the Social Sciences (SPSS), version 17.0 for Windows.
Deviation of the genotype counts from the Hardy–Weinberg
equilibrium was tested by employing a Chi-Square goodness-of-fit
test. Chi-Square test was used for gender comparisons between
genetic groups. Age, years of education, facial emotion perception
and composite cognition between genetic groups was test by
ANOVA. Bonferroni correction was used in post-hoc analysis.
Linkage disequilibrium structure was examined using Haploview
4.2 [60] with solid spine D9.0.80 (Figure S1). MET haplotype
and diplotype were reconstructed via SAS/GENETICS by
implementing the PROC HAPLOTYPE procedure (SASH 9.1
software). Because MET could induce phosphorylation of AKT
[39], interactions between MET and AKT may be present in facial
emotion perception. Therefore, this study divided subjects into
four groups according to the genotype status and function
assessment in the previous studies [29,32,37,41,44] to explore
potential interactions between MET (rs2237717) and AKT
(rs1130233) genotypes. The four groups of MET/AKT were
TT/AA, TT/G carrier, C carrier/AA, and C carrier/G carrier.
General linear models (GLM) were utilized to test the main
effects of MET, AKT, and MET/AKT combination on facial
emotion perception, and control variables were age, gender, and
years of education as covariates or fixed factors as appropriate.
This study utilized partial g2 (eta squared) by SPSS [61] to
estimate the effect size in GLM. We also calculated the effect sizes
(Cohen’s d) [62] of the MET, AKT, and MET/AKT status to testify
whether the combined gene effect was additive or synergistic.
Finally, this study utilized G* power 3 [63] to estimate the power
and defined the results as statistically significant if the p-values
were below 0.05 (two-sided).
Results
All four SNPs of MET and AKT rs1130233 did not deviate from
the Hardy-Weinberg equilibrium. Genotype and allele frequencies
of the five SNPs were similar to those of other studies [37,64,65]
(Table 1 and Table S1). There were high linkage among MET
rs2237717, rs41735, and rs42336 (D9.0.9); therefore, we
constructed haplotype block among the 3 SNPs (Figure S1). In
this haplotype block, the most common two haplotypes from MET
rs2237717, rs41735, and rs42336 were CGA and TAG (frequen-
cy=0.505, 0.425, respectively). There were only 2 subjects with
CAG haplotype, and their mean [SD] facial emotion perception
(88.9[11.0]) was similar to that (84.3[20.5]) of the TAG group; we
therefore combined CAG with TAG as the non-CGA group.
Demographic characteristics and emotion perception perfor-
mance by MET genotype, AKT genotype, MET haplotypes, and
MET-AKT are shown in Table 1. Age, gender, and years of
education were similar among groups by MET genotypes, AKT
genotypes, or CGA haplotype.
Performances of facial emotion perception were different
among 3 genotype groups of MET rs2237717 (p=0.048,
F=3.09, df=2). Bonferroni post hoc analysis revealed this
difference was driven from difference between CT and TT
(p=0.049; uncorrected p=0.016, power=0.699). There was a
dominant effect of the C allele of MET rs2237717, since there was
no difference between CT and CC in terms of performance. No
differences of facial emotion perception were observed in the other
three MET SNPs and AKT rs113023 (Table 1). MET CGA
haplotype had significant effect on facial emption perception
(p=0.018, df=1, F=5.69). Subjects with MET CGA haplotype
also performed better than non-CGA individuals in facial emotion
perception by GLM analysis (p=0.009) (Table 2).
Considering the combined effect of MET and AKT variants, we
analyzed MET rs2237717 and AKT rs1130233 simultaneously.
Facial emotion perceptions were different among four combina-
tions of MET/AKT variants (p=0.031, df=3, F=3.03). The
Bonferroni post-hoc analysis showed that the difference was driven
from the comparison between the individuals who were simulta-
neously C carriers and G carriers and those with TT/AA
(p=0.035, uncorrected p=0.006). In addition, there was nominal
difference between TT/AA and C carrier/AA (p=0.049);
however it did not survive after Bonferroni correction (p=0.296).
As shown on Table 2, after control for age, gender, and
education duration, CC and CT genotypes of MET rs2237717in-
creased facial emotion perception by 9.987, 8.766, respectively
(p=0.015, 0.018, respectively) when compared with TT genotype.
As for MET rs42336, AA homozygotes had better performance
than those with GG genotype by 8.686 (p=0.041). Subjects with
MET CGA haplotype had better emotion perception by 8.748
than those without this haplotype (p=0.009). However, MET
rs41735, rs1858830 and AKT rs1130233 did not affect facial
emotion perception (Table 2). In addition, each year increase in
education duration increased performance of facial emotion
perception by 1.86–2.06 (data not shown). Men had better facial
emotion perception than women by 4.87 (p=0.048) in general
linear regression analysis for MET rs2237717. Other confounding
variables did not significantly influence facial emotion perception.
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chose MET rs2237717 and AKT rs1130233, because MET
rs2237717 had the most significant influence on facial emotion
perception in the current study and AKT rs1130233 had been
shown to be functional in the previous studies [41,44]. In the
general linear analysis controlling age, gender, and education, the
overall effect of MET/AKT on facial emotion perception was
significant (p=0.041). When the individuals who were C carrier
and G carrier simultaneously were used as the reference group,
their facial emotion perception was better than that of those with
TT/AA (p=0.015, Table 2). To inspect the influence of the
combined effect of both genes on facial emotion perception, effect
sizes of MET rs2237717, AKT rs1130233, and MET/AKT
combination were compared (Figure 1).This result showed a
possible additive effect of the two genes on facial emotion
perception.
To evaluate the possible effect of cognitive functions on facial
emotion perception, we further explored the 149 patients who also
received thorough cognition assessments. Demographic data and
facial emotion perception in the 149 patients Table S2) were
similar to those in the all 182 subjects. MET rs2237717, MET
CGA haplotype and MET/AKT combination still had significant
Table 1. Demographics and facial emotion perception of individuals with different MET SNPs, MET CGA haplotypes, AKT SNP, and
MET/AKT interaction variants.
Male/Female Age (SD) Education (SD)
Facial emotion
perception (SD)
MET- rs2237717
CC 19/34 31.4(10.6) 14.4(2.3) 91.9(21.2)
CT 40/48 31.7(9.1) 15.2(1.7) 93.0(18.4)
TT 23/18 31.2(9.4) 14.8(2.9) 83.9(20.9)
p
* 0.147 0.962 0.097 0.048
MET- rs41735
GG 21/33 30.7 (9.8) 14.63(2.2) 91.5(22.0)
GA 45/47 32.2(9.4) 15.20(2.1) 92.3(18.7)
AA 16/20 31.2(9.9) 14.58(2.5) 85.1(20.0)
p
* 0.500 0.643 0.204 0.175
MET- rs42336
GG 19/18 31.4(9.8) 14.7(3.0) 84.7(20.5)
AG 45/48 31.6(8.9) 15.3(1.8) 92.3(18.9)
AA 18/34 31.5(10.7) 14.4(2.2) 91.9(21.4)
p
* 0.192 0.993 0.063 0.127
MET- rs1858830
GG 37/42 32.1(10.1) 15.0(2.3) 91.1(20.0)
GC 35/51 31.5(9.4) 14.8(2.2) 90.5(21.1)
CC 10/7 29.1(8.2) 15.1(1.6) 89.5(15.1)
p
* 0.357 0.498 0.687 0.924
MET- CGA
carrier 58/79 31.6(9.7) 14.9(1.9) 92.7(19.7)
Non carrier
{ 24/21 31.1(9.2) 15.0(2.9) 84.5(20.1)
p
* 0.198 0.758 0.865 0.018
AKT- rs1130233
AA 23/32 30.3(9.4) 14.6(2.4) 87.0(20.2)
AG 42/49 32.8(9.9) 14.9(2.0) 91.4(22.0)
GG 17/19 30.1(8.7) 15.4(2.4) 94.6(12.9)
p
* 0.841 0.199 0.199 0.190
MET-AKT
{
TT/AA 6/8 31.5(10.0) 13.9(3.1) 80.0 (18.4)
TT/G carrier 17/10 31.1(9.4) 15.3(2.8) 87.0(21.7)
C carrier/AA 17/24 29.9(9.3) 14.8(2.2) 90.1(20.1)
C carrier/G carrier 42/58 32.3(9.8) 15.1(1.7) 93.7(13.2)
p
* 0.249 0.599 0.279 0.031
*Chi-Square test for gender comparison; ANOVA for other items.
{Non carriers of CGA include those with TAG or CAG.
{MET rs2237717/AKT rs1130233.
doi:10.1371/journal.pone.0036143.t001
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facial emption perception.
*
Genetic variance Estimated coefficient
Standard error of
estimated coefficient p Power
MET- rs2237717
CC vs. TT 9.987 4.069 0.015 0.44
CT vs. TT 8.766 3.683 0.018 0.70
MET- rs41735
GG vs. AA 6.675 4.213 0.115 0.28
GA vs. AA 5.585 3.883 0.152 0.48
MET- rs42336
GG vs. AA 28.686 4.219 0.041 0.35
GA vs. AA 22.099 3.450 0.544 0.05
MET- rs1858830
GG vs. CC 2.075 5.303 0.696 0.068
GC vs. CC 2.497 5.268 0.636 0.076
MET- CGA
Carrier vs non-carrier 8.748 3.329 0.009 0.66
AKT- rs1130233
AA vs. GG 25.733 4.250 0.179 0.51
AG vs. GG 22.737 3.887 0.482 0.13
MET-AKT
{
TT/AA
{ 213.626 5.572 0.015 0.81
TT/G carrier
{ 28.136 4.237 0.056 0.34
C carrier/AA
{ 22.744 3.613 0.449 0.17
*Age, gender, and education years, used as covariates.
{MET rs2237717/AKT rs1130233.
{Compared with C carrier(CT+CC)/G carrier(GA+GG).
doi:10.1371/journal.pone.0036143.t002
Figure 1. MET rs2237717 and AKT rs1130233 combined effect on facial emotion perception. Compared with TT/AA of MET/AKT, C carrier/
G carrier had a Cohen’s d (0.822), which was similar with the sum (0.704) of Cohen’s d of MET rs2237717 (d=0.439) and AKT rs1130233 (d=0.265),
indicating an additive effects of the two SNPs on facial emotion perception.
doi:10.1371/journal.pone.0036143.g001
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variants had no significant influence on cognitive function (Table
S2). Effects of MET/AKT variants were also analyzed by general
linear regression analysis in the 149 subjects. After control for age,
gender, education duration, and neurocognition, subjects with CC
and CT genotypes of MET rs2237717 had better facial emotion
perception when compared with TT genotype(p=0.035, 0.037,
respectively). Subjects with MET CGA haplotype had better
emotion perception than those without this haplotype (p=0.020)
(details not shown). The participants who were C carrier/G carrier
of MET/AKT were superior to those with TT/AA in facial
emotion perception (p=0.046, Table 3). Neurocognition did not
affect facial emotion perception (Table 3).
Discussion
Sensory perception, especially facial emotion recognition, is
crucial for social skill in humans [66]. To our knowledge, this
study is the first one which demonstrates that genes can affect
performance of facial emotion perception. The findings suggest
that MET’s rs2237717 genotype and CGA haplotype from
rs2237717, rs41735, and rs42336 of can alter facial emotion
perception, and that AKT gene may enhance the influence of MET
on facial emotion perception. The C allele of rs1858830 in the
MET promoter region has been reported to be associated with
autism [29,30]; however, the current study failed to find its
influence on facial emotion perception. One of the possible
explanations is the different ethnicities. Previous Japanese and
Chinese studies [65,67] also did not find an association between
MET rs1858830 and autism, but did find an association between
MET rs38841 and 38845 and autism [65,67]. In genetic studies,
different associated variants may be reported in the same region in
heterogeneous disorders such as autism and schizophrenia [68].
Burdick et al [37] found that the haplotype GCAATACA from
rs38857- rs10215153- rs2237717- rs2283053- rs41735- rs41741-
rs42336- rs41750 of MET was associated with better neurocog-
nitive ability in healthy subjects. However, CGA haplotype in the
current study did not affect cognitive function (Table S1). The
possible reasons include differences in cognitive tests, ethnicity,
and haplotypes between studies.
The A allele of AKT rs1130233 was reported to be associated
with reduced cognitive functions [44]; the current study showed
the same trend for facial emotion perception, albeit statistically
insignificant (Table S1) (perhaps due to the modest sample size).
AKT is also involved with emotional memory learning in the
amygdala, which is a critical area in emotion perception [45]. In
spite of insignificant effect of AKT variants on facial emotion
perception, the present study revealed that AKT had additive effect
with MET on facial emotion perception: the individuals who were
both C carriers/G carriers of MET/AKT had better emotion
perception than those with TT/AA. Therefore, this finding
suggests that the AKT gene may modulate the MET effect on
facial emotion perception. Such gene-gene interactions are pretty
common in CNS signal pathways. One recent example is the
interaction of Neuregulin-1 (NRG-1) and its receptor, ERBB4
[69,70]. Schizophrenia patients who carried 3 NRG1/ERBB4/
AKT risk genotypes were disproportionately worse in dorsolateral
prefrontal function in the image study [69].
Consistent with a previous study [71], the current study showed
that higher education level was associated with better facial
emotion perception. However, MET genotype, haplotype and
MET/AKT combination still exerted significant effects on facial
emotion perception after control for education level.
The present study had some limitations, such as utilizing the
face task of the emotion perception branch of MSCEIT, which
only reflects the general ability of facial emotion perception.
However, the face task of emotion perception can also be an
important component of social cognition [4,72,73]. Second, this
study focused on healthy Han-Chinese subjects. Whether the
finding can be extrapolated to mentally ill patients or other races
remain unknown. Third, the sample size in this study was only
modest; however, the power of effects of MET and MET/AKT was
medium to large. Future studies with larger samples in other
ethnicities are warranted.
In summary, the results suggest that the MET/AKT cascade
may play a role in facial emotion perception. Further studies in
other races or in patients with mental disorders such as
schizophrenia are needed.
Supporting Information
Figure S1 Linkage disequilibrium (D9) for the MET SNPs was
computed using Haploview 4.2.
(TIF)
Table S1 Allele frequencies of MET SNPs and AKT SNP.
(DOC)
Table 3. General linear regression analysis of the MET/AKT variants for facial emption perception in 149 subjects who also received
comprehensive cognitive tests.
Parameter Estimated coefficient
Standard error of
estimated coefficient p Power
Male vs. female 7.338 3.614 0.044
Age, y 0.186 0.194 0.338
Education, y 1.547 0.938 0.101
Composite cognition
* 0.160 0.185 0.390
MET-AKT
{
TT/AA
{ 212.890 6.394 0.046 0.73
TT/G carrier
{ 29.199 5.097 0.073 0.42
C carrier/AA
{ 23.265 4.182 0.436 0.22
MATRICS overall composite T score [58].
{MET rs2237717/AKT rs1130233.
{Compared with C carrier(CT+CC)/G carrier(GA+GG).
doi:10.1371/journal.pone.0036143.t003
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cognitive assessments.
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